Global Health Ventures, Inc. (OTC:GHLV) has earned investor interest with the completion of its prototype for its male enhancement drug X-Excite. The drug is expected to work faster, and be safer than Pfizer’s Viagra. Other drugs in development with the company include T-Slim, an anti-obesity drug, and Nico-Z, a nicotine craving suppressant.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
A healthcare technology financial company, Global Health Ventures is focused on the over the counter drug market. The company is also exploring a new proprietary platform technology that delivers drugs sublingually, under the tongue. The sublingual method delivers low doses of the drug directly to the blood stream which eliminates digestive and liver system side effects and maintains product efficacy.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Us
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
